Национальная программа
 Скачать 0.83 Mb.
|
|
135. El-Hajj Fuleihan G., Nabulsi M., Tamim H. et al. Effect of vitamin D replacement on musculoskeletal parameters in school children: a randomized controlled trial. J. Clin. Endocrinol. Metab. 2006; 91: 405–412. 136. Ziegler E.E., Nelson S.E., Jeter J.M. Vitamin D supplementation of breastfed infants: a randomized dose-response trial. Pediatr. Res. 2014; 76 (2): 177–183. 137. Natarajan C.K., Sankar M.J., Agarwal R. et al. Trial of daily vitamin D supplementation in preterm infants. Pediatrics. 2014; 133 (3): 628–634. 138. Wagner C.L., McNeil R., Hamilton S.A. et al. A randomized trial of vitamin D supplementation in 2 community health center networks in South Carolina. Am. J. Obstet. Gynecol. 2013; 208 (2): 137e1–13. 139. Grant C.C., Stewart A.W., Scragg R. et al. Vitamin D during pregnancy and infancy and infant serum 25-hydroxyvitamin D concentration. Pediatrics. 2014; 133 (1): 143–153. 140. Oberhelman S.S., Meekins M.E., Fischer P.R., Lee B.R. Maternal vitamin D supplementation to improve the vitamin D status of breast- fed infants: a randomized controlled trial. Mayo Clin. Proc. 2013; 88 (12): 1378–1387. 141. Ala-Houhala M., Koskinen T., Terho A. et al. Maternal compared with infant vitamin D supplementation. Arch. Dis. Child. 1986; 61 (12): 1159–1163. 142. Camargo C.A.Jr, Rifas-Shiman S.L., Litonjua A.A. et al. Maternal intake of vitamin D during pregnancy and risk of recurrent wheeze in children at 3 y of age. Am. J. Clin. Nutr. 2007; 85 (3): 788–795. 50 143. Grant C.C., Kaur S., Waymouth E. et al. Reduced primary care respiratory infection visits following pregnancy and infancy vitamin D supplementation: a randomised controlled trial. Acta Paediatr. 2014; Oct: 11–19. 144. Al-Shaar L., Mneimneh R., Nabulsi M. et al. Vitamin D3 dose requirement to raise 25-hydroxyvitamin D to desirable levels in adolescents: results from a randomized controlled trial. J. Bone Miner. Res. 2014; 29 (4): 944–951. 145. Nader N.S., Aguirre Castaneda R., Wallace J. et al. Effect of vitamin D3 supplementation on serum 25(OH)D, lipids and markers of insulin resistance in obese adolescents: a prospective, randomized, placebo-controlled pilot trial. Horm. Res. Paediatr. 2014; 82 (2): 107–112. 146. Radhakishun N.N., van Vliet M., Poland D.C et al. Efficacy and tolerability of a high loading dose (25,000 IU weekly) vitamin D3 sup- plementation in obese children with vitamin D insufficiency/deficiency. Horm. Res. Paediatr. 2014; 82 (2): 103–106. 147. Walker G.E., Ricotti R., Roccio M. et al. Pediatric obesity and vitamin D deficiency: a proteomic approach identifies multimeri- cadiponectin as a key link between these conditions. PLoS One. 2014; 9 (1): 83685. 148. Wingate K.E., Jacobson K., Issenman R. et al. 25-Hydroxyvitamin D concentrations in children with Crohn'sdisease supplemented with either 2000 or 400 IU daily for 6 months: a randomized controlled study. J. Pediatr. 2014; 164 (4): 860–865. 149. Khadgawat R., Marwaha R.K., Garg M.K. et al. Impact of vitamin D fortified milk supplementation on vitamin D status of healthy school children aged 10–14 years. Osteoporos. Int. 2013; 24 (8): 2335–2343. 150. Abrams S.A., Hawthorne K.M., Chen Z. Supplementation with 1000 IU vitamin D/d leads to parathyroid hormone suppression, but not increased fractional calcium absorption, in 4-8-y-old children: a double-blind randomized controlled trial. Am. J. Clin. Nutr. 2013; 97 (1): 217–223. 151. Maalouf J., Nabulsi M., Vieth R. et al. Short- and long-term safety of weekly high-dose vitamin D3 supplementation in school children. J. Clin. Endocrinol. Metab. 2008; 93 (7): 2693–2701. 152. McNally J.D., Iliriani K., Pojsupap S. et al. Rapid Normalization of Vitamin D Levels: A Meta-Analysis. Pediatrics. 2015; 135 (1): 152– 166. 153. Pojsupap S., Iliriani K., Sampaio T.Z. et al. Efficacy of high-dose vitamin D in pediatric asthma: a systematic review and meta-analysis. J. Asthma. 2014; Nov 21: 1–9. 154. Ganmaa D., Giovannucci E., Bloom B.R. et al. Vitamin D, tuberculin skin test conversion, and latent tuberculosis in Mongolian school- age children: a randomized, double-blind, placebo-controlled feasibility trial. Am. J. Clin. Nutr. 2012; 96 (2): 391–396. 155. Marchisio P., Consonni D., Baggi E. et al. Vitamin D supplementation reduces the risk of acute otitis media in otitis-prone children. Pediatr. Infect. Dis. J. 2013; 32 (10): 1055–1060. 156. Camargo C.A.Jr, Ganmaa D., Sidbury R. et al. Randomized trial of vitamin D supplementation for winter-related atopic dermatitis in children. J. Allergy Clin. Immunol. 2014; 134 (4): 831–835. 157. Urashima M., Segawa T., Okazaki M., Kurihara M. Randomized trial of vitamin D supplementation to prevent seasonal influenza A in schoolchildren. Am. J. Clin. Nutr. 2010; 91 (5): 1255–1260. 158. Mikati M.A., Dib L., Yamout B. et al. Two randomized vitamin D trials in ambulatory patients on anticonvulsants: impact on bone. Neu- rology. 2006; 67 (11): 2005–2014. 159. Громова О.А., Торшин И.Ю., Гоголева ИВ. и др. Органические соли кальция перспективы использования в клинической практике. РМЖ. 2014; 28: 1407–1412. 160. Спиричев В.Б., Громова О.А. Витамин D и его синергисты. Земский врач. 2012; 2: 16–19. 161. Громова О.А., Торшин И.Ю., Пронин А.В. Особенности фармакологии водорастворимой формы витамина D на основе мицелл. Фарматека. 2015; 1: 46–49. 162. Mikati M.A., Dib L., Yamout B. et al. Two randomized vitamin D trials in ambulatory patients on anticonvulsants: impact on bone. Neu- rology. 2006; 67 (11): 2005–2014. 163. Мальцев СВ. К дискуссии о рахите. Педиатрия. Журн. им. Г.Н.Сперанского. 2008; 87; 2; 120. 164. Мальцева ЛИ, Васильева Э.Н., Денисова Т.Г. Витамин D и преэклампсия. Российский вестник акушера-гинеколога. 2016; 16 (1): 79–83. 165. Kuryaninova V.A., Klimov L.Ya. et al. The relationship between nutrition and vitamin D sufficiency in infants and children under three years of age residing in South of Russia. JPGN. 2016; 62 (1): 781. 166. Gilad L.A., Schwartz B. Association of estrogen receptor beta with plasma-membrane caveola components: implication in control of vitamin D receptor. J. Mol. Endocrinol. 2007; 38 (6): 603. 167. Kuryaninova V.A., Klimov L.Ya. et al. Influence of duration of cholecalciferol products administration on the efficacy of hypovitaminosis D prevention in children during first year of life. Euro. J. Pediatr. 2016; 175; 343. 168. Торшин И.Ю., Громова О.А. Экспертный анализ данных в молекулярной фармакологии. М МЦНМО, 2013. 169. Мальцева ЛИ, Васильева Э.Н. Новые подходы к оценке роли витамина D в репродуктивном здоровье женщин. Практическая медицина. 2014; 2: 211–213. 170. Захарова И.Н., Климов ЛЯ, Долбня СВ. и др. Схема профилактики и коррекции недостаточности витамина D у детей раннего возраста эффективность и безопасность водного раствора холекальциферола. Consilium Medicum. Педиатрия (Прил 4; 86–93. |